ArticleCell communication and signaling : CCS2025
KLC3 regulates axonemal glutamylation via RAB11/FIP5 in polycystic kidney disease.
Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic value of neuro-related genes in colorectal cancer and their potential implications for immunotherapy.Journal of Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
KLC3 was identified as a novel ciliary gene in a previous study that caused cyst formation due to abnormal ciliary defects in cyst-lining cells of polycystic kidney disease (PKD) models. RAB11FIP5 is a regulator of tubulin post-translational modification (PTM) in primary cilia and is located on basal bodies. Here, we determined the relationship between KLC3 and RAB11FIP5 mediated tubulin PTM, which may be involved in cyst progression in patients with PKD. KLC3 co-localizes and interacts with RAB11FIP5 around the basal bodies of primary cilia. KLC3 regulates axonemal glutamylation accompanied by changes in RAB11FIP5 expression in basal bodies, which may be involved in anterograde ciliary trafficking. Similarly, in previous KLC3 results, increased RAB11FIP5 and axonemal glutamylation were observed in the cyst-lining cells of PKD. When the increased KLC3 in ADPKD patient-derived cells decreased, not only ciliary glutamylation and IFT88, but also cell proliferation decreased. Our findings suggest that KLC3 regulates ciliary glutamylation mediated by RAB11FIP5 and it may contribute to cyst progression in PKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.